6 Meridian’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,475
Closed -$176K 401
2020
Q4
$176K Sell
11,475
-217
-2% -$2.75K 0.02% 303
2020
Q3
$141K Buy
11,692
+1,071
+10% +$10.2K 0.01% 258
2020
Q2
$108K Sell
10,621
-15,174
-59% -$156K 0.01% 333
2020
Q1
$269K Buy
+25,795
New +$324K 0.03% 395

Other funds holding ANGO

6 Meridian's ANGO Position: Q1 2021 in Review

6 Meridian sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 11,475 shares — an estimated $176K sold.

6 Meridian first reported a position in ANGO in Q1 2020 and held it in 4 quarters. The position peaked at $269K in Q1 2020. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

  • 6 Meridian reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
  • 6 Meridian sold 11,475 AngioDynamics shares in Q1 2021, an estimated $176K.
  • 6 Meridian first reported a position in AngioDynamics in Q1 2020 and held it in 4 quarters.
  • 6 Meridian's AngioDynamics position peaked at $269K in Q1 2020.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on 6 Meridian's 13F filing for Q1 2021, filed 22 Apr 2021.